Compare Rockwell Automation (ROK) vs Summit Therapeutics Inc (SMMT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Rockwell Automation vs Summit Therapeutics Inc — how do they compare? Rockwell Automation trades at $466.2 (market cap $51.04B), while Summit Therapeutics Inc trades at $14.57 (market cap $10.48B). The key difference: Rockwell Automation is far larger — about 4.9× Summit Therapeutics Inc's market cap, and Rockwell Automation pays a 1.2% dividend while Summit Therapeutics Inc pays none. Which is the better fit depends on your goals.
| ROK | SMMT | |
|---|---|---|
Market Cap | $51.04B | $10.48B |
Sector | Industrials | Health |
52-Week High | $495.08 | $29.32 |
52-Week Low | $328.67 | $13.05 |
Enterprise Value | $54.67B | $9.90B |
Dividend Yield | 1.2% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Rockwell Automation
Rockwell Automation is a pure-play automation competitor that is the successor entity to Rockwell International, which spun off its former Rockwell Collins avionics segment in 2001. As of fiscal 2021, the firm operates through three segments--intelligent devices, software and control, and lifecycle services. Intelligent devices contains its drives, sensors, and industrial components, software and control contains its information and network and security software, while lifecycle services contains its consulting and maintenance services as well as its Sensia JV with Schlumberger.
Read more on ROK →About Summit Therapeutics Inc
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →
